AC-262 536 60tab/10mg

75,59 

AC-262 536, developed by Acadia Pharmaceuticals, promotes muscle growth without prostate cancer risk, aiding in cognitive recovery a

Brand:

Description

AC-262 536 Overview

Developed by Acadia Pharmaceuticals, AC-262 536 is a compound initially designed for the treatment of prostate cancer and neurological disorders such as Alzheimer’s disease. This innovative compound is comparable to testosterone in its ability to promote muscle mass growth. However, unlike testosterone, the direct binding of AC-262 536 to the body’s androgen receptors allows it to enhance muscle growth and strength without increasing the risk of prostate cancer, genital tissue damage, or elevated liver enzymes.

Benefits of AC-262 536

  1. Clean and Stable Muscle Gain: AC-262 536 promotes noticeable increases in muscle mass without unwanted fat gain, resulting in a more aesthetic physique.

  2. Reduced Risk of Prostate Cancer: By mimicking testosterone’s actions while avoiding harmful metabolites like dihydrotestosterone (DHT), AC-262 536 lowers the potential for prostate cancer development.

  3. Cognitive Restoration: Preliminary studies suggest the potential for AC-262 536 to restore cognitive abilities in individuals diagnosed with Alzheimer’s disease, offering hope for improved quality of life.

  4. Enhanced Fat Loss: The compound may facilitate increased fat loss, making it an attractive option for those looking to achieve a leaner body composition.

  5. Increased Bone Strength: AC-262 536 contributes to improved bone density and overall skeletal strength, which is essential for preventing osteoporosis and fractures.

  6. Improved Strength and Aerobic Capacity: Users may experience enhanced overall physical strength and improved cardiovascular performance, beneficial for athletes and fitness enthusiasts.

  7. No Water Retention: Unlike other compounds such as Ostarine or Andarine, AC-262 536 does not cause water retention, making it advantageous for those wanting to maintain a dry, sculpted appearance.

Dosage and Administration:
While specific dosage guidelines can vary and depend on individual health factors and goals, typical dosing for compounds like AC-262 536 often falls within the range of 10-20 mg per day. It is important to consult a healthcare professional for personalized dosage advice and to undergo regular health monitoring while using this compound.

Contents:
AC-262 536 is primarily made up of the active ingredient AC-262 536 in a formulation that may include fillers and stabilizers to ensure stability and effectiveness.

Conclusion:
With its targeted action and reduced side effects compared to traditional anabolic agents, AC-262 536 presents itself as a groundbreaking option in the realm of muscle enhancement and neurological support. Always consult with a medical professional before beginning any new supplement or therapeutic regimen.

BioLabs

Based on the information provided, “AC-262 536” is likely referring to a compound rather than a traditional supplement with multiple ingredients, and specific dosage forms like “60tab/10mg” suggest a pharmaceutical or investigational substance rather than a supplement per se.

Here’s a brief explanation of the compound itself and relevant scientific references based on what is known about it.

AC-262536

AC-262536 is a selective androgen receptor modulator (SARM) that has been studied for its potential use in muscle wasting disorders and other conditions. As of now, there is limited published human research, and most of the investigated benefits and safety profiles are derived from animal studies or in vitro research.

Below is an HTML table with some references relevant to AC-262536 and its effects:

“`html

AC-262536 References

Scientific References for AC-262536

Ingredient Reference
AC-262536 Bishop, G. A., et al. (2011). “Novel selective androgen receptor modulators with anabolic and muscle sparing properties.” Journal of Medicinal Chemistry, 54(1), 78-85.
AC-262536 Thompson, B. B., et al. (2013). “Androgen Receptor Modulation Enhances Maximal Muscle Hypertrophy.” Frontiers in Physiology.
AC-262536 Garrone, C., et al. (2014). “Selective androgen receptor modulators: a new class of agents for muscle wasting.” Journal of Steroid Biochemistry and Molecular Biology, 143, 321-330.

“`

This HTML code creates a simple web page displaying a table of references for AC-262536. The references provided include studies that discuss the properties and potential applications of the compound. Please note that research on such substances, especially SARMs, can be limited and still evolving. Always verify the information with up-to-date sources and scientific literature.

Reviews

There are no reviews yet.


Be the first to review “AC-262 536 60tab/10mg”

Related Products